Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Luminal B Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Large-scale testing (Phase 3)Study completedNCT01314833
What this trial is testing

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Who this might be right for
Primary Breast Cancer
Fudan University 1,570
Not applicableStudy completedNCT03715959
What this trial is testing

Nipple Aspirate Fluid in Detecting Breast Cancer

Who this might be right for
Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+25 more
Ohio State University Comprehensive Cancer Center 2
Testing effectiveness (Phase 2)UnknownNCT05640778
What this trial is testing

Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)

Who this might be right for
Luminal B/HER2-negative Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Not applicableUnknownNCT01779531
What this trial is testing

Compare the Outcomes of XT and XEC Adjuvant Chemotherapy in HER2-negative Luminal B Breast Cancer Patients

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Guangdong Academy of Medical Sciences 640
Not applicableUnknownNCT04403984
What this trial is testing

Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes

Who this might be right for
Breast Cancer
Hellenic Cooperative Oncology Group 750
Testing effectiveness (Phase 2)WithdrawnNCT03841747
What this trial is testing

Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Queen Mary University of London
Testing effectiveness (Phase 2)Study completedNCT04659551
What this trial is testing

Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients

Who this might be right for
Breast Cancer
Istituto Oncologico Veneto IRCCS 43
Not applicableLooking for participantsNCT07776951
What this trial is testing

Physical Activity and Healthy Aging: Promoting Cardio-metabolic Capacity to Fight Chronic Inflammation and Improve Outcomes in Breast Cancer Patients (PhActHealth Study)

Who this might be right for
Breast Cancer
University of Milan 126
Testing effectiveness (Phase 2)UnknownNCT03712956
What this trial is testing

CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER

Who this might be right for
Breast Cancer
European Institute of Oncology 63
Testing effectiveness (Phase 2)Study completedNCT01669252
What this trial is testing

Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 163
Not applicableEnded earlyNCT01984866
What this trial is testing

CPR Prediction After Neoadjuvant Using Excisional Biopsy By Radiofrequency In Breast Cancer From II-III UICC Stages.

Who this might be right for
Triple Negative, HER2+, Luminal B Breast Tumors (Stages II-III)in Female Patients
Hospital General Universitario Gregorio Marañon 13
Post-approval studies (Phase 4)UnknownNCT03799692
What this trial is testing

Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer

Who this might be right for
HER-2 Negative Breast Cancer
Fudan University 78
Not applicableStudy completedNCT03719833
What this trial is testing

Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents

Who this might be right for
Breast CancerSentinel Lymph Node BiopsyNeoadjuvant Chemotherapy
Clinical Hospital Center Rijeka 230